Cargando…
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
SIMPLE SUMMARY: Pancreatic cancer is the fourth leading cause of cancer death in the United States and over 90% of the patients suffer from pancreatic ductal adenocarcinoma (PDAC). PDAC is the most lethal gastrointestinal malignancies and only 10% of the people survive more than 5 years, therefore,...
Autores principales: | Uddin, Md. Hafiz, Al-Hallak, Mohammed Najeeb, Philip, Philip A., Mohammad, Ramzi M., Viola, Nerissa, Wagner, Kay-Uwe, Azmi, Asfar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199777/ https://www.ncbi.nlm.nih.gov/pubmed/34204940 http://dx.doi.org/10.3390/cancers13112777 |
Ejemplares similares
-
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
por: Li, Yiwei, et al.
Publicado: (2021) -
Gastric Cancer Heterogeneity and Clinical Outcomes
por: Sexton, Rachel E., et al.
Publicado: (2020) -
Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
por: Sasaki, Reina, et al.
Publicado: (2019) -
Exosomes in multiple myeloma: from bench to bedside
por: Menu, Eline, et al.
Publicado: (2022) -
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
por: To, Kenneth KW, et al.
Publicado: (2018)